New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments
- Author
- Shaji Kumar MD, Natalie S. Callander MD
- Published
- Tue 01 Sep 2020
- Episode Link
- https://oncologypodcast.simplecast.com/episodes/new-advances-in-relapsed-refractory-multiple-myeloma-frequently-asked-questions-on-current-and-emerging-treatments-7nw0l1or
In this episode, Natalie S. Callander, MD, and Shaji Kumar, MD, answer audience questions from a live CCO Webinar on relapsed/refractory myeloma regarding challenges in treating patients in this setting, including optimizing treatment choices and sequencing of treatments, MRD testing in myeloma, promising BCMA-targeted agents, the promise and value of CAR T-cell therapy in myeloma, and more.
Presenters:
Natalie S. Callander, MD
Professor of Medicine
Director, Myeloma Clinical Program
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin
Shaji Kumar, MD
Department of Hematology
Mayo Clinic
Rochester, Minnesota
Content based on an online CME program supported by educational grants from GlaxoSmithKline LLC and Sanofi Genzyme.
Link to full program, including associated downloadable slidesets:
